You have 9 free searches left this month | for more free features.

Sipuleucel-T (Sip-T)

Showing 1 - 25 of 8,128

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in Oklahoma City (Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T
  • Oklahoma City, Oklahoma
    Stephenson's Cancer Center
Mar 28, 2023

Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • New Haven, Connecticut
    Yale Cancer Center
Oct 20, 2023

Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

Recruiting
  • Prostate Cancer
  • Metastatic Prostate Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Feb 21, 2023

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial (Sipuleucel-T Injection)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • Sipuleucel-T Injection
  • (no location specified)
Nov 10, 2023

Metastatic Castrate-resistant Prostate Cancer, mCRPC Trial in Dallas (Sipuleucel-T, Stereotactic Ablative Body Radiation)

Completed
  • Metastatic Castrate-resistant Prostate Cancer
  • mCRPC
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 11, 2022

Prostate Cancer Trial in United States (Radium-223, Sipuleucel-T)

Completed
  • Prostate Cancer
  • Los Angeles, California
  • +4 more
Jun 15, 2021

Prostate Cancer Trial in San Francisco, Houston (SipT Treatment, Ipilimumab)

Completed
  • Prostate Cancer
  • San Francisco, California
  • +1 more
Jul 19, 2021

Hormone-Resistant Prostate Cancer, Metastatic Malignant Tumor in the Bone, Recurrent Prostate Carcinoma Trial in Buffalo,

Completed
  • Hormone-Resistant Prostate Cancer
  • +3 more
  • Laboratory Biomarker Analysis
  • Radiation Therapy
  • Buffalo, New York
  • +1 more
Aug 4, 2021

Prostate Cancer Metastatic Trial in Duarte, Marina Del Rey, Honolulu (Atezolizumab1200 mg IV, Sipuleucel-T)

Completed
  • Prostate Cancer Metastatic
  • Duarte, California
  • +2 more
May 24, 2021

Prostate Cancer Trial in Madison (sipuleucel-T, DNA Vaccine)

Completed
  • Prostate Cancer
  • sipuleucel-T
  • DNA Vaccine
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Jun 15, 2021

Prostate Cancer Recurrent Trial in Indianapolis (Low protein diet, Control protein diet)

Completed
  • Prostate Cancer Recurrent
  • Low protein diet
  • Control protein diet
  • Indianapolis, Indiana
  • +1 more
Mar 25, 2021

Metastatic Castrate-Resistant Prostate Cancer Treated With

Completed
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Dec 22, 2020

Adenocarcinoma of the Prostate Trial in United States (sipuleucel-T)

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • sipuleucel-T
  • Gilbert, Arizona
  • +55 more
Jan 18, 2022

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City

Completed
  • Adenocarcinoma of the Prostate
  • +5 more
  • sipuleucel-T
  • +2 more
  • Duarte, California
  • +2 more
Aug 21, 2020

Metastatic Prostate Cancer Trial in United States (Indoximod, Sipuleucel-T, Placebo)

Completed
  • Metastatic Prostate Cancer
  • Indoximod
  • +2 more
  • Chicago, Illinois
  • +3 more
Mar 20, 2020

Prostate Cancer Trial in Durham (Sipuleucel-T, Lymph Node Biopsy)

Completed
  • Prostate Cancer
  • Durham, North Carolina
    Duke University Medical Center
Mar 30, 2020

Adverse Childhood Experiences Trial (FACE self-help App)

Not yet recruiting
  • Adverse Childhood Experiences
  • FACE self-help App
  • (no location specified)
Apr 19, 2023

NEC, Atresia, Malrotation Trial (Perfusion assessment by means of the SPY-PHI camera)

Not yet recruiting
  • NEC
  • +3 more
  • Perfusion assessment by means of the SPY-PHI camera
  • (no location specified)
Feb 3, 2023

Prostatic Tumors Trial in Augusta (CT-011 (Anti-PD1 Antibody), Sipuleucel-T (Provenge), Cyclophosphamide)

Terminated
  • Prostatic Neoplasms
  • CT-011 (Anti-PD1 Antibody)
  • +2 more
  • Augusta, Georgia
    Georgia Regents University
Jun 18, 2019

Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • CAR-T Therapy
  • Hefei, Anhui, China
  • +7 more
Jul 31, 2023

Periodontal Diseases Trial in Turin (Decontamination of the pocket with local doxycycline, Decontamination of the pocket with

Recruiting
  • Periodontal Diseases
  • Decontamination of the pocket with local doxycycline
  • Decontamination of the pocket with mechanical instrumentation
  • Turin, Italy
    CIR Dental School
May 17, 2023

Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)

Recruiting
  • Multiple Myeloma
  • APRIL-BAFF-Bicephali CAR-T cells
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 14, 2023

Spinal Cord Injury Trial in Bronx (Natesto testosterone intranasal gel, Ayr Saline Nasal Gel)

Not yet recruiting
  • Spinal Cord Injury
  • Natesto testosterone intranasal gel
  • Ayr Saline Nasal Gel
  • Bronx, New York
    James J. Peters VA Medical Center, Bronx, NY
Nov 8, 2023

Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial in Germany (Cyclophosphamide (Non-IMP,

Not yet recruiting
  • Acute Myeloid Leukemia, in Relapse
  • Acute Myeloid Leukemia Refractory
  • Cyclophosphamide (Non-IMP, Lymphodepletion)
  • +3 more
  • Ulm, Baden-Württemberg, Germany
  • +4 more
Jul 24, 2023

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

Not yet recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • CD7-CART01
  • (no location specified)
Sep 26, 2023